No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / mortality
-
Breast Neoplasms / radiotherapy*
-
Carcinoma in Situ / drug therapy
-
Carcinoma in Situ / mortality
-
Carcinoma in Situ / radiotherapy*
-
Carcinoma, Intraductal, Noninfiltrating / drug therapy
-
Carcinoma, Intraductal, Noninfiltrating / mortality
-
Carcinoma, Intraductal, Noninfiltrating / radiotherapy*
-
Combined Modality Therapy
-
Female
-
Humans
-
Prognosis
-
Risk Factors
-
Survival Rate